Literature DB >> 23123298

Helenalin-induced apoptosis is dependent on production of reactive oxygen species and independent of induction of endoplasmic reticulum stress in renal cell carcinoma.

Ji Hoon Jang1, Taha Iqbal, Kyoung-Jin Min, Shin Kim, Jong-Wook Park, Eun-Ik Son, Tae-Jin Lee, Taeg Kyu Kwon.   

Abstract

Helenalin, a sesquiterpene lactone, exhibits anti-inflammatory and anti-tumor activities. Here, we investigated whether helenalin could induce apoptosis in human renal carcinoma Caki cells. Helenalin increased apoptosis in dose dependent manner in Caki cells, and also induced apoptosis in other carcinoma cells, such as human renal carcinoma ACHN cells, human colon carcinoma HT29 and HCT116 cells. We found that helenalin markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, activating transcription factor-4 (ATF4) and/or the CCAAT enhancer-binding protein-homologous protein (CHOP). However, down-regulation of ATF4 and/or CHOP expression by siRNA had no effect on helenalin-induced apoptosis in Caki and HCT116 cells. Helenalin increased production of intracellular reactive oxygen species (ROS). Furthermore, ROS scavengers, N-acetylcystine (NAC), and glutathione ethyl ester (GEE), reduced helenalin-induced apoptosis. Taken together, helenalin induced apoptosis via ROS generation in human renal carcinoma Caki cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123298     DOI: 10.1016/j.tiv.2012.10.014

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  9 in total

Review 1.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

2.  In vitro metabolism of helenalin and its inhibitory effect on human cytochrome P450 activity.

Authors:  Michaela Šadibolová; Risto O Juvonen; Seppo Auriola; Iva Boušová
Journal:  Arch Toxicol       Date:  2022-01-06       Impact factor: 5.153

Review 3.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

4.  Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells.

Authors:  Ji-Hoon Jang; In-Hwan Song; Eon-Gi Sung; Tae-Jin Lee; Joo-Young Kim
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

5.  EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress.

Authors:  Zheng Xu; Yunjie Zhao; Peng Zhong; Jingying Wang; Qiaoyou Weng; Yuanyuan Qian; Jibo Han; Chunpeng Zou; Guang Liang
Journal:  Oncotarget       Date:  2017-05-16

6.  Biological Activity of Flavonoids and Rare Sesquiterpene Lactones Isolated From Centaurea ragusina L.

Authors:  Ulrike Grienke; Sandra Radić Brkanac; Valerija Vujčić; Ernst Urban; Siniša Ivanković; Ranko Stojković; Judith M Rollinger; Juran Kralj; Anamaria Brozovic; Marijana Radić Stojković
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

Review 7.  Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases.

Authors:  Jae-Ung Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

8.  A sensitive sensor cell line for the detection of oxidative stress responses in cultured human keratinocytes.

Authors:  Ute Hofmann; Melanie Priem; Christine Bartzsch; Thomas Winckler; Karl-Heinz Feller
Journal:  Sensors (Basel)       Date:  2014-06-25       Impact factor: 3.576

9.  Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells.

Authors:  Hakmin Mun; Helen Elizabeth Townley
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.